Jannie Borst
Universiteit Leiden
H-index: 87
Europe-Netherlands
Top articles of Jannie Borst
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors | Cellular & Molecular Immunology | Xin Lei Daniël C de Groot Marij JP Welters Tom de Wit Ellen Schrama | 2024/2/21 |
PD-1 and CTLA-4 blockade promote CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in mice | The Journal of Clinical Investigation | Elselien Frijlink Douwe MT Bosma Julia Busselaar Thomas W Battaglia Mo D Staal | 2024/2/13 |
Treg cells from human blood differentiate into non-lymphoid tissue-resident effector cells upon TNFR2 costimulation | JCI insight | Mark Mensink Lotte J Verleng Ellen Schrama George MC Janssen Rayman TN Tjokrodirijo | 2024/1/30 |
Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells | Cell Reports Medicine | Jenny Sprooten Isaure Vanmeerbeek Angeliki Datsi Jannes Govaerts Stefan Naulaerts | 2024/1/16 |
Identifying the nature of Tregs in human pregnancy | Journal of Reproductive Immunology | Lotte J Verleng Mark Mensink Ellen Schrama Hanneke Kapsenberg Juliette Krop | 2023/9/1 |
CD4+ helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment | Nature Communications | Xin Lei Indu Khatri Tom de Wit Iris de Rink Marja Nieuwland | 2023/1/13 |
Immune checkpoints targeting dendritic cells for antibody-based modulation in cancer. | Xin Lei Yizhi Wang Chayenne Broens Jannie Borst Yanling Xiao | 2023/8/12 | |
Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer | Science Translational Medicine | Stefan Naulaerts Angeliki Datsi Daniel M Borras Asier Antoranz Martinez Julie Messiaen | 2023/4/12 |
N-terminal acetylation can stabilize proteins independent of their ubiquitination | Scientific Reports | Bert van de Kooij Evert de Vries Rogier W Rooswinkel George MC Janssen Frédérique K Kok | 2023/4/1 |
A lymph node-to-tumour PDL1+macrophage circuit antagonizes dendritic cell immunotherapy | bioRxiv | Jenny Sprooten Isaure Vanmeerbeek Angeliki Datsi Jannes Govaerts Daniel M Borràs | 2023/3/15 |
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer | Oncoimmunology | Raquel S Laureano Jenny Sprooten Isaure Vanmeerbeerk Daniel M Borras Jannes Govaerts | 2022/12/31 |
Proteomics reveals unique identities of human TGF-β-induced and thymus-derived CD4+ regulatory T cells | Scientific reports | Mark Mensink Ellen Schrama Eloy Cuadrado Derk Amsen Sander de Kivit | 2022/11/24 |
TNFR2 costimulation differentially impacts regulatory and conventional CD4+ T-cell metabolism | Mark Mensink Thi Ngoc Minh Tran Esther A Zaal Ellen Schrama Celia R Berkers | 2022/6/30 | |
Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy | Journal for Immunotherapy of Cancer | Lars Guelen Thierry O Fischmann Jerelyn Wong Smita Mauze Marco Guadagnoli | 2022 |
Immunogenomic, single-cell and spatial dissection of CD8+T cell exhaustion reveals critical determinants of cancer immunotherapy | BioRxiv | Stefan Naulaerts Daniel M Borras Asier Antoranz Martinez Julie Messiaen Yannick Van Herck | 2021/11/22 |
Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells | Cell reports | Elisa Matas-Rico Elselien Frijlink Irene van der Haar Àvila Apostolos Menegakis Maaike van Zon | 2021/11/16 |
Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses | Cancer Immunology, Immunotherapy | Jesper van Eck van der Sluijs Diede van Ens Soley Thordardottir Denise Vodegel Inge Hermens | 2021/11 |
Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy | Jannie Borst Julia Busselaar Douwe MT Bosma Ferry Ossendorp | 2021/8 | |
Flagellin/TLR5 stimulate myeloid progenitors to enter lung tissue and to locally differentiate into macrophages | Frontiers in Immunology | Xin Lei Jara Palomero Iris De Rink Tom De Wit Martijn Van Baalen | 2021/3/19 |
GPA33: A marker to identify stable human regulatory T cells | The Journal of Immunology | Rianne Opstelten Sander de Kivit Manon C Slot Maartje van den Biggelaar Dorota Iwaszkiewicz-Grześ | 2020/6/15 |
Co-Authors
